The Alzheimer’s economy: is the new $56,000-a-year drug worth it?
阿尔茨海默氏症manbetx20客户端下载 ：每年56,000美元的新药值得吗？

US approval of the Biogen treatment has given patients hope. But some experts worry expectations have been raised too high
百健公司的治疗方法在美国获批，给患者带来了希望。但一些专家担心期望值被抬得太高了。